Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Methylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117024485A reveals a scalable synthesis method for 2'-OMe adenosine. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Advanced synthesis of 5-trifluoromethyl-2'-deoxyuridine via patent CN100334100C. Offers cost reduction in antiviral agent manufacturing and high-purity pharmaceutical intermediates supply.
Novel patent CN117024485B details safe methylation route for 2'-OMe adenosine, offering cost reduction and scalability for pharmaceutical intermediate supply chains.